NuVasive insider sells 4k+ shares: 5 key points

NuVasive insider Matthew Link sold more than 4,000 shares of the company’s stock, according to a Ticker Report article.

Advertisement

Here are five things to know:

 

•    Mr. Link sold 4,078 shares
•    Average share price was $45.77
•    Total transaction was valued at $186,650
•    Mr. Link now directly owns 67,655 shares
•    His shares are valued at approximately $3.09 million

 

NuVasive has a one-year low of $31.35 and a one-year high of $51.23. The company’s shares have appreciated by 0.89 percent over the last week.

More articles on devices:

Amedica brings on with PCG Advisory as agency of record
OrthoWorx commits $475k on workforce development — 6 initiatives
Mesoblast gets patent for mesenchymal precursor cell technology — 7 thing to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.